Recent Quotes (30 days)

You have no recent quotes
chg | %

Pyng Medical Corp.  

(Public, CVE:PYT)   Watch this stock  
Find more results for PYT
May 28 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.02 - 0.07
Open     -
Vol / Avg. 0.00/11,313.00
Mkt cap 825,560.00
P/E     -
Div/yield     -
EPS -0.03
Shares 23.59M
Beta 0.21
Inst. own     -
May 26, 2015
Q2 2015 Pyng Medical Corp Earnings Release

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -7.20% -15.09%
Operating margin 0.43% -8.54%
EBITD margin - 3.77%
Return on average assets -7.16% -11.93%
Return on average equity -12.40% -21.76%
CDP Score - -


210 - 13480 Crestwood Place
+1-604-3037964 (Phone)
+1-604-3037987 (Fax)

Website links


Pyng Medical Corp. (Pyng) is a Canada-based medical device company that develops, manufactures and markets a suite of trauma and resuscitation products. The Company’s product portfolio includes Sternal Intraosseous (sternal IO), pelvic stabilization and tourniquet devices specifically designed for both the military and civilian markets. Pyng develops medical devices for use by hospital staff, emergency medical services and military forces. Its products include FASTResponder, Fast1 Sternal IO, Fastcombat Sternal IO, T-Podresponder Pelvic Stabilization Device, T-Podcombat Pelvic Stabilization Device, Matresponder Tourniquet and Matcombat Tourniquet. The Company operates in Canada and the United States.

Officers and directors

Ronald Blanck Independent Chairman of the Board
Mark F. Hodge President, Chief Executive Officer
George G. Dorin Chief Financial Officer, Corporate Secretary
Age: 62
Robert Di Silvio Director
Age: 61
Alan L. Moloff Director
Herbert A. Toms III Director
L. J. Evans Jr. Independent Director